How Much Did Inceptive Raise?
Funding & Key Investors

Inceptive, a Palo Alto-based biotechnology firm, has secured significant enterprise-level funding, with its total capital raised standing at $100M. The company recently announced a major strategic investment of $100M, underscoring its pivotal role in advancing biological software development. This latest financing round highlights the growing investor confidence in Inceptive's innovative approach to creating programmable biological systems for novel medicines and biotechnologies.

What is Inceptive?

Inceptive
Business ServicesResearch & Development

Founded in 2021, Inceptive is at the forefront of biological software development. The company specializes in creating synthetic molecules designed to execute complex functions within biological systems, guided by programmatic instructions. Inceptive's core mission is to develop advanced tools for the rational design of new medicines and biotechnologies that were previously considered unattainable. Their work aims to unlock unprecedented capabilities in biological engineering, paving the way for more accessible and powerful biotechnological solutions.

How much funding has Inceptive raised?

Inceptive has raised a total of $100M across 1 funding round:

2023

Other Financing Round

$100M

Other Financing Round (2023): $100M with participation from NVIDIA and Andreessen Horowitz

Key Investors in Inceptive

NVIDIA

NVIDIA is a global technology leader specializing in GPUs and AI computing solutions, likely providing Inceptive with expertise in high-performance computing and AI infrastructure crucial for complex biological simulations and data analysis.

Andreessen Horowitz

Andreessen Horowitz is a prominent venture capital firm known for investing in both early-stage and growth-stage technology companies, suggesting a strategic interest in Inceptive's disruptive potential within the biotech and software sectors.

What's next for Inceptive?

The substantial enterprise-level backing Inceptive has garnered, particularly the recent strategic investment, positions the company for accelerated growth and innovation. This infusion of capital is expected to fuel further research and development into their biological software platform, enabling the company to scale its operations and expand its reach. Inceptive is likely to focus on translating its cutting-edge technology into tangible products, potentially targeting complex diseases or developing novel industrial biotechnologies. The strategic nature of the recent financing suggests a focus on market penetration and the establishment of key partnerships to commercialize their groundbreaking work.

See full Inceptive company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesResearch & DevelopmentAerospace & DefenseManufacturing
Accounting for Legal PracticesBusiness ServicesProject Management
Business ServicesResearch & Development
Advertising NetworksBusiness Services

Frequently Asked Questions Regarding Inceptive Financial Insights

What are the most recent funding rounds that Inceptive has completed, and what were the funding rounds?
Inceptive has recently completed 1 funding rounds: Other Financing Round on Sep 8, 2023.
What is the total amount of funding Inceptive has raised to date?
Inceptive has raised a total of $100M in funding to date.
How many funding rounds has Inceptive completed?
Inceptive has completed 1 funding rounds.
How much funding did Inceptive raise in its most recent funding round?
Inceptive raised $100M in its most recent funding round.
Who are the lead investors in Inceptive's latest funding round?
The lead investor in Inceptive's latest funding round was NVIDIA. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Inceptive's history?
The largest funding round in Inceptive's history was $100M.
See more information about Inceptive